BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

STU:BX2 (USA)  
€ 1.73 (+4.3%) May 27
At Loss
Market Cap:
€ 64.36M ($ 70.05M)
Enterprise V:
€ 90.02M ($ 97.98M)
Volume:
-
Avg Vol (2M):
1.95K
Also Trade In:

BioXcel Therapeutics Inc Valuation Measures